Privium Fund Management’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Privium Fund Management’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-179,262	Closed	-$471K	–	207
2022 Q3	$471K	Buy	+179,262	New	+$264K	0.17%	66

Other funds holding CANO.WS

Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Privium Fund Management's CANO.WS Position: Q4 2022 in Review

Privium Fund Management sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2022, closing a stake of 179,262 shares — an estimated $471K sold.

Privium Fund Management first reported a position in CANO.WS in Q3 2022 and held it in 1 quarter. The position peaked at $471K in Q3 2022. 27 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2022.

Privium Fund Management reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2022 after selling out during the quarter.
Privium Fund Management sold 179,262 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2022, an estimated $471K.
Privium Fund Management first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q3 2022 and held it in 1 quarter.
Privium Fund Management's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $471K in Q3 2022.
27 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2022.

Based on Privium Fund Management's 13F filing for Q4 2022, filed 3 Feb 2023.